ARCOMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ARCOMA
Largest movements
- Cash -€10,979
down €10,979 (-48.4%), from €22,702 to €11,723
mainly Net result for the year (-€14,665) and Investment in fixed assets (net) (-€4,823)
- Receivables within one year -€3,927
down €3,927 (-31.5%), from €12,464 to €8,537
of which Trade receivables: -€3,786
- Reserves -€13,000
down €13,000 (-24.4%), from €53,259 to €40,259
- Profit (loss) carried forward -€1,665
down €1,665 (-97.1%), from €1,714 to €49
- Financial income -€12,069
no longer reported in 2025 (was €12,069)
of which Non-recurring financial income: -€12,068
- Other operating charges +€4,214
up €4,214 (+317%), from €1,331 to €5,545
- Gross operating margin -€196
down €196 (-4.5%), from -€4,336 to -€4,531
- Depreciation -€180
down €180 (-3.9%), from €4,680 to €4,500
- Financial charges +€63
up €63 (+241%), from €26 to €89
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €64,501 | €49,918 | -€14,583 | -22.6% |
| Fixed assets | 21/28 | €29,335 | €29,658 | +€323 | +1.1% |
| Tangible fixed assets | 22/27 | €29,335 | €29,658 | +€323 | +1.1% |
| Land and buildings | 22 | €24,756 | €26,766 | +€2,009 | +8.1% |
| Plant, machinery and equipment | 23 | €4,578 | €2,892 | -€1,686 | -36.8% |
| Current assets | 29/58 | €35,166 | €20,260 | -€14,906 | -42.4% |
| Amounts receivable within one year | 40/41 | €12,464 | €8,537 | -€3,927 | -31.5% |
| Trade receivables | 40 | €11,846 | €8,060 | -€3,786 | -32.0% |
| Other amounts receivable | 41 | €618 | €477 | -€141 | -22.8% |
| Cash at bank and in hand | 54/58 | €22,702 | €11,723 | -€10,979 | -48.4% |
| Total equity and liabilities | 10/49 | €64,501 | €49,918 | -€14,583 | -22.6% |
| Equity | 10/15 | €61,173 | €46,508 | -€14,665 | -24.0% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Reserves | 13 | €53,259 | €40,259 | -€13,000 | -24.4% |
| Distributable reserves | 133 | €53,259 | €40,259 | -€13,000 | -24.4% |
| Profit (loss) carried forward | 14 | €1,714 | €49 | -€1,665 | -97.1% |
| Amounts payable | 17/49 | €3,328 | €3,409 | +€82 | +2.5% |
| Amounts payable within one year | 42/48 | €3,328 | €3,409 | +€82 | +2.5% |
| Trade debts | 44 | €1,328 | €1,409 | +€82 | +6.1% |
| Suppliers | 440/4 | €1,328 | €1,409 | +€82 | +6.1% |
| Other amounts payable | 47/48 | €2,000 | €2,000 | = | 0.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,680 | €4,500 | -€180 | -3.9% |
| Other operating charges | 640/8 | €1,331 | €5,545 | +€4,214 | +317% |
| Gross operating margin | 9900 | -€4,336 | -€4,531 | -€196 | -4.5% |
| Operating profit (loss) | 9901 | -€10,347 | -€14,576 | -€4,229 | -40.9% |
| Financial income | 75/76B | €12,069 | - | -€12,069 | |
| Recurring financial income | 75 | €1 | - | -€1 | |
| Non-recurring financial income | 76B | €12,068 | - | -€12,068 | |
| Financial charges | 65/66B | €26 | €89 | +€63 | +241% |
| Recurring financial charges | 65 | €26 | €89 | +€63 | +241% |
| Profit (loss) for the period before taxes | 9903 | €1,696 | -€14,665 | -€16,361 | |
| Profit (loss) for the period | 9904 | €1,696 | -€14,665 | -€16,361 | |
| Profit (loss) for the period to be appropriated | 9905 | €1,696 | -€14,665 | -€16,361 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 22 October 2026 via checked.be.